Evidence map›Paper›PMID 38248114›Full record

Observational studyCurrent oncology (Toronto, Ont.)2024

Head and Neck Cancer Patient Population, Management, and Oncologic Outcomes from the COVID-19 Pandemic.

Julie R Bloom, Carlos Rodriguez-Russo, Kristin Hsieh, Daniel R Dickstein, Ren-Dih Sheu, Mayuri Jain, Erin Moshier, Jerry Liu, Vishal Gupta, Diana N Kirke and 6 more

Abstract readObservational Study
In one paragraph

Observational study in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Julie R BloomDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Carlos Rodriguez-RussoDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Kristin HsiehDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0003-4100-473X
Daniel R DicksteinDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Ren-Dih SheuDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Mayuri JainDepartment of Population Health Science and Policy, Tisch Cancer Institute Biostatistics Shared Resource Facility, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Erin MoshierDepartment of Population Health Science and Policy, Tisch Cancer Institute Biostatistics Shared Resource Facility, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0002-8912-4709
Jerry LiuDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Vishal GuptaDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Diana N KirkeDepartment of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Scott RoofDepartment of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Krzysztof MisiukiewiczDepartment of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Marshall PosnerDepartment of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Richard BakstDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Kunal K SindhuDepartment of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0001-9376-8307
Sonam SharmaDepartment of Radiation Oncology, Summit Health, Berkeley Heights, NJ 07922, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic precipitated drastic changes in cancer care. Its impact on the U.S. head and neck cancer population has yet to be fully understood. This study aims to understand the impact of pandemic-related changes on the head and neck cancer population. An observational study of head and neck cancer patients at a single institution during the spring of 2020 and 2019 was performed. Clinical characteristics and survival outcomes were analyzed. In 2020, 54 head and neck cancer patients were evaluated in the department of radiation oncology vs. 74 patients seen in 2019; 42% of the patients were female in 2019 versus 24% in 2020 (

Indexed as

COVID-19Head and Neck NeoplasmsRadiation OncologyFemaleHumansMaleMedical OncologyPandemicsCOVID-19gender disparityhead and neck cancerinduction chemotherapyradiation therapy

Identifiers

PMID38248114
PMCPMC10814981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.